ANTIBIOTICE IASI
78 articole · RSS
Antibiotice Iasi Opens New Plant in Wake of EUR20M Investment
Romanian pharmaceutical manufacturer Antibiotice Iasi is opening a new plant, in the wake of a EUR20 million investment, with a 50% higher production capacity than the existing unit.
Antibiotice Iasi Revenue Up 47% YoY To RON361.7M In Jan-Sept 2022
Romanian pharmaceutical manufacturer Antibiotice Iasi (ATB.RO) said in a stock market report on Friday that it ended the first nine months of 2022 with sales revenue of RON361.7 million, up...
Antibiotice Iasi Plans to Invest RON300M in Coming Years
Romanian drug maker Antibiotice Iasi has budgeted RON300 million investments for the following years.
Antibiotice Iasi Net Profit Spikes 114% YoY To RON8.6M In 1Q/2022
Antibiotice Iasi (ATB.RO), the biggest Romanian-held drug maker, reported a net profit net of RON8.6 million for the first three months of 2022, up 113.7% from the year-earlier period, in li...
Antibiotice Iasi Eyes RON448M Revenues and RON32M Net Profit in 2022
Antibiotice Iasi (ATB.RO), the biggest local Romanian-held drug producer, projects total revenues worth RON448 million in 2022, up 15% on the year and net profit of RON32 million, 6% higher...
Antibiotice Iasi Wants 60% of Sales to Come From Abroad by 2028
Antibiotice Iasi, the biggest local Romanian-held drug maker, aims for exports to weigh 50%-60% in turnover by 2028.
Antibiotice Iasi Turnover Up 10% To RON161M, Net Profit Up Nearly 1% To RON19.3M In 1H/2021
Antibiotice Iasi (ATB.RO), the largest Romanian-held pharmaceutical producer, reported sales of RON161.4 million in the first half of 2021, up 10.2% from the same period in 2020, per calcula...
Antibiotice Iasi 1Q Sales Drop 10% To RON66M, Net Profit Of RON4.03M, Close To Level In Year-Earlier Period
Antibiotice Iasi (ATB.RO), the largest Romanian-held pharmaceutical producer, on Wednesday reported sales of RON66.1 million for the first quarter of 2021, down 10.2% on the year, and a net...
Antibiotice Iasi Shareholders Approve RON2.22M Dividends From 2020 Profit, At 0.6% Yield
Shareholders of state-run Antibiotice Iasi (ATB.RO), the largest pharmaceutical producer in Romania, on Wednesday approved the distribution of dividends worth RON2.2 million from the 2020 pr...